), an industrial gas producer and supplier, announced price hikes
for industrial, specialty and medical gases for its customers in
the U.S., Canada, and Puerto Rico.
Prices of nitrogen, oxygen, hydrogen, helium and carbon dioxide
have been revised up to 15%. Facility fees or monthly bulk product
charges and cylinder rental rates have gone up by 10% while prices
for hardgoods have also risen by 10%.
Praxair cited higher cost of production and distribution, feedstock
sourcing and other operational factors as the primary reasons
behind this revision. The revised rates will be applicable to bulk
and packaged gas customers, effective Jul 15, 2014.
Earlier, in Apr 2014, price of argon was increased up to 20% while
argon facility fees or monthly bulk product charges went up by 15%.
These revised rates were applicable for Praxair's bulk and packaged
industrial, and specialty customers in the U.S. and Puerto Rico.
We believe Praxair's profitability is highly dependent on costs of
sales and expenses as any unwarranted increase in these will lower
profitability and vice versa. In the past five years, the company's
cost of sales has increased by 34%.
Praxair is slated to report its second-quarter results on Jul 23,
2014 before the market opens. The Zacks Consensus Estimate is
pegged at $1.59 for the quarter, and at $6.45 for 2014 and $7.20
for 2015. These estimates represent year-over-year growth of 6.4%
for the second quarter, 8.8% for 2014 and 11.7% for 2015. Earnings
in the next five years are anticipated to grow 11.7%.
Praxair presently has a $38.9 billion market capitalization and
carries a Zacks Rank #3 (Hold). Some better-ranked stocks in the
Koninklijke DSM N.V.
PPG Industries Inc.
). All these stocks hold a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research?
Today, you can download 7 Best Stocks for the Next 30 Days.
Click to get this free report
PPG INDS INC (PPG): Free Stock Analysis Report
PRAXAIR INC (PX): Free Stock Analysis Report
CELANESE CP-A (CE): Free Stock Analysis Report
KONINKLIJKE DSM (RDSMY): Get Free Report
To read this article on Zacks.com click here.